首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1956255

日本泛自閉症障礙市場規模、佔有率、趨勢和預測：按自閉症類型、治療方法和地區分類，2026-2034年

Japan Autism Spectrum Disorder Market Size, Share, Trends and Forecast by Autism Type, Treatment, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本泛自閉症障礙）市場規模達1.0982億美元。預計到2034年，該市場規模將達到2.8782億美元，2026年至2034年的複合年成長率（CAGR）為11.30% 。成長要素包括：政府主導的醫療改革擴大了兒童和青少年獲得心理健康服務的管道；數位醫療和遠端醫療服務模式；以及由於檢測準確率的提高，泛自閉症障礙患病率上升，從而推高了治療需求。此外，對早期療育計畫和專業治療機構的日益重視也促進了日本泛自閉症障礙市場佔有率的擴大。

日本泛自閉症障礙市場趨勢：

透過政府主導的保險改革擴大精神科醫療服務的覆蓋範圍。

日本政府透過厚生勞動省實施了旨在改善神經發育障礙兒童和青少年心理健康服務的全面保險改革。這些政策顯著改善了全國泛自閉症障礙的治療狀況。這項始於2014年的保險改革透過提供經濟獎勵，擴大了青少年門診精神科服務。這解決了專業心理健康人員嚴重短缺的問題，並減輕了尋求治療的家庭的經濟負擔。政府在意識到多家醫療機構的候診名單超過300人，且發育障礙患者通常需要等待三個月以上才能獲得初次諮詢後，立即採取了相應的政策措施。這些措施的顯著成效體現在全國門診心理治療的保險理賠數量幾乎加倍，從2015年的每萬名兒童521例增至2022年的1034.5例。不過，各地的實施情況存在差異。根據2024年《兒童青少年精神科專業短缺指數》，德島縣註冊兒童青少年精神科醫生的數量和專科醫療機構數量均顯著增加，這表明資源配置方面取得的進展遠超醫療費用數據所顯示的水平。透過結合國家財政獎勵措施和為18歲以下兒童提供免費醫療服務的市級項目，在不增加家庭經濟負擔的情況下擴大服務範圍成為可能，從而顯著提高了日本各年齡層和各地區的醫療服務利用率。

數位醫療和遠端醫療的加速普及正在改變醫療服務的提供方式。

在日本，數位健康科技和遠端醫療平台正經歷前所未有的成長，從根本上改變了泛自閉症障礙的治療方式以及全國各地的精神健康服務提供方式。人口快速老化和醫療資源獲取方面的區域差異，推動了創新數位解決方案的普及，這些方案能夠實現遠距醫療和持續的病患監測。自2014年修訂《藥事法》以來，日本政府積極支持這項轉型，推行前瞻性的政策和措施，並啟動了許多計劃，以支持遠端醫療平台、電子健康記錄（EHR）和其他數位健康工具的發展。 CureApp是日本先驅企業，它為更多數位健康解決方案的出現鋪平了道路。據估計，日本遠端醫療產業在2024年市場規模將達到14億美元，並有望以20.3%的複合年成長率成長，到2033年達到72億美元。這一成長主要得益於日本政府在新冠疫情期間放寬了遠距遠端醫療監管，這使得人們重新認知到遠端醫療服務的價值，並加速了全球數位醫療解決方案的普及。高度發展的數位基礎設施，包括廣泛的網際網路接入和先進的行動網路，以及政府的大力支持和消費者對數位化醫療解決方案日益成長的信心，共同為遠端醫療市場的擴張創造了非常有利的環境。人工智慧（AI）和數據分析正遠端醫療平台中，以提高診斷準確性、個人化治療方案並簡化行政流程。機器學習演算法正在分析醫療數據，以預測患者的治療結果並識別泛自閉症障礙患者的潛在健康風險。

泛自閉症障礙盛行率上升和檢測準確率提高

日本泛自閉症障礙）市場的成長主要受泛自閉症障礙及相關神經發育障礙在各年齡層中盛行率和檢出率顯著上升的推動。一項利用國民健康保險醫療費用資料庫進行的全國性綜合調查證實，泛自閉症障礙的診斷率和盛行率均顯著上升，反映出醫療專業人員、相關人員和公眾對該疾病的認知度不斷提高。 2024年，日本18歲以下族群的自殺死亡人數達到創紀錄的524人，凸顯了泛自閉症障礙症（ADHD）相關的嚴重公共衛生問題。這些疾病的診斷需要及時進行精神科干預，且在全國範圍內呈快速成長趨勢。 0至19歲青少年接受認知行為療法的索賠數量從2014年的691例（佔所有心理治療索賠的1.5%）大幅成長至2022年的4497例（佔12.8%），所有年齡段的兒童均呈現出顯著的成長趨勢。診斷能力的提升、透過在嬰兒3-5個月、18個月和36個月齡時進行定期健康檢查（參與率超過95%）而實施的系統性篩檢計劃，以及專門發育診所的建立，都促進了自閉症頻譜病例的早期準確識別。教育機構的認知水平和篩檢能力也得到了提高，《學校教育法》現已將泛自閉症障礙認定為一種獨立的殘疾類別。因此，現在可以透過特殊教育、特殊教育班級和資源教室等途徑獲得適當的支持。據估計，全國約有159,000名自閉症兒童在各種環境中接受教育支持。

本報告解答的主要問題

日本泛自閉症障礙市場目前發展狀況如何？預計未來幾年將如何發展？
日本泛自閉症障礙市場依自閉症類型分類的細分如何？
日本泛自閉症障礙市場依治療方法分類的組成是怎樣的？
日本泛自閉症障礙市場的區域分佈如何？
日本泛自閉症障礙市場價值鏈的不同階段有哪些？
日本泛自閉症障礙市場的主要促進因素和挑戰是什麼？
日本泛自閉症障礙市場的結構是怎麼樣的？主要企業有哪些？
日本泛自閉症障礙市場競爭有多激烈？

The Japan autism spectrum disorder market size reached USD 109.82 Million in 2025 . The market is projected to reach USD 287.82 Million by 2034 , exhibiting a growth rate (CAGR) of 11.30% during 2026-2034 . The market is driven by government-led insurance changes that increase children's and teenagers' access to mental health services, accelerated digital health and telemedicine adoption transforming healthcare delivery, and rising prevalence with improved detection of autism spectrum disorder driving treatment demand. Additionally, the growing focus on early intervention programs and specialized treatment centers is expanding the Japan autism spectrum disorder market share.

JAPAN AUTISM SPECTRUM DISORDER MARKET TRENDS:

Government-Led Insurance Reforms Expanding Access to Psychiatric Services

The Japanese government has implemented comprehensive insurance reforms through the Ministry of Health, Labour, and Welfare aimed at improving mental health services for children and adolescents with neurodevelopmental disorders. These policy initiatives have dramatically transformed the accessibility landscape for autism spectrum disorder treatment across the nation. The insurance reforms offered financial incentives starting in 2014 to increase outpatient psychiatric care explicitly targeting young populations, addressing the acute shortage of specialist mental health practitioners and lessening the financial burden on families seeking treatment. The government took immediate policy action after realizing that several institutions had waitlists of more than three hundred people and that first consultations for developmental disorders often took longer than three months. The significant impact of these policy measures is demonstrated by the nearly twofold increase in outpatient psychotherapy claims nationwide from 521.0 per 10,000 kids in fiscal year 2015 to 1034.5 in fiscal year 2022. Regional differences in implementation have surfaced. According to the 2024 Japan Child Mental Health Professional Shortage Areas index, Tokushima Prefecture has significantly increased the number of board-certified specialists and specialized facilities in its child and adolescent psychiatry workforce, indicating actual improvements in resource availability beyond billing data. Combining national financial incentives with municipal programs that provide free medical care for children under the age of eighteen has made it possible to expand services without placing further financial strain on families, which has greatly increased service utilization across all age groups and geographical areas of Japan.

Accelerated Digital Health and Telemedicine Adoption Transforming Healthcare Delivery

Japan is experiencing unprecedented growth in digital health technologies and telemedicine platforms, fundamentally reshaping how autism spectrum disorder treatment and mental health services are delivered throughout the country. The rapid aging population, combined with geographical disparities in healthcare access, has catalyzed the adoption of innovative digital solutions that enable remote consultations and continuous patient monitoring. Since amending the Pharmaceutical Act in 2014, the Japanese government has actively supported this transition by putting forward-thinking policies and initiatives into place and initiating a number of projects to assist telemedicine platforms, electronic health records, and other digital health tools. After receiving Japan's first regulatory approval in 2020, CureApp, a trailblazing firm in digital therapeutics, opened the door for more digital health solutions. The telehealth industry in Japan was estimated to be worth USD 1.4 billion in 2024 and is expected to increase at a compound yearly growth rate of 20.3 percent to reach USD 7.2 billion by 2033. The government's relaxation of telemedicine laws during the COVID-19 pandemic, which emphasized the value of remote healthcare services and sped up the adoption of digital health solutions worldwide, is what is driving this expansion. The country's highly developed digital infrastructure, characterized by widespread internet penetration and sophisticated mobile networks, combined with strong government support and increasing consumer trust in digital health solutions, creates an exceptionally favorable environment for telemedicine market expansion. Artificial intelligence and data analytics are being increasingly integrated into telehealth platforms to enhance diagnostic accuracy, personalize treatment plans, and streamline administrative tasks, with machine learning algorithms analyzing medical data to predict patient outcomes and identify potential health risks for individuals with autism spectrum disorder.

Rising Prevalence and Improved Detection of Autism Spectrum Disorder

The Japan Autism Spectrum Disorder market growth is propelled by the increasing prevalence and substantially improved detection rates of autism spectrum disorder and related neurodevelopmental conditions across all age groups. Japan has witnessed marked increases in both the incidence and prevalence of autism spectrum disorder diagnoses, confirmed by comprehensive nationwide studies utilizing the National Database of Health Insurance Claims, reflecting heightened awareness among healthcare professionals, educators, and the general public. With 524 suicide deaths among individuals under the age of eighteen in fiscal year 2024, the highest number ever recorded in Japan and highlighting the serious public health issue of autism spectrum disorder and attention-deficit hyperactivity disorder diagnoses that require prompt psychiatric intervention have been sharply rising throughout the nation. Cognitive behavioral therapy claims for Japanese youth aged zero to nineteen years increased markedly from 691 cases representing 1.5 percent of all psychotherapy claims in fiscal year 2014 to 4,497 cases representing 12.8 percent in fiscal year 2022, with significant upward trends observed across all pediatric age groups. The expansion of diagnostic capabilities, implementation of systematic screening programs through regular infant health checkups at three to five months, eighteen months, and thirty-six months with participation rates exceeding ninety-five percent, and the development of specialized developmental clinics have collectively contributed to earlier and more accurate identification of autism spectrum disorder cases. Educational institutions have enhanced their awareness and screening capabilities, with the School Education Act recognizing autism spectrum disorder as a discrete category of disability, enabling children to receive appropriate support through schools for special needs education, specialized classes, and resource rooms, with estimates indicating approximately 159,000 children with autism receiving educational support across various settings nationwide.

JAPAN AUTISM SPECTRUM DISORDER MARKET SEGMENTATION:

Autism Type Insights:

Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder
Childhood Disintegrative Disorder

Treatment Insights:

Behavioral Approach
Early Intervention
Medication
Dietary Approach
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan autism spectrum disorder market performed so far and how will it perform in the coming years?
What is the breakup of the Japan autism spectrum disorder market on the basis of autism type?
What is the breakup of the Japan autism spectrum disorder market on the basis of treatment?
What is the breakup of the Japan autism spectrum disorder market on the basis of region?
What are the various stages in the value chain of the Japan autism spectrum disorder market?
What are the key driving factors and challenges in the Japan autism spectrum disorder market?
What is the structure of the Japan autism spectrum disorder market and who are the key players?
What is the degree of competition in the Japan autism spectrum disorder market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Autism Spectrum Disorder Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Autism Spectrum Disorder Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Autism Spectrum Disorder Market - Breakup by Autism Type

6.1 Autistic Disorder
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Asperger Syndrome
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Pervasive Developmental Disorder
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Childhood Disintegrative Disorder
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)

7 Japan Autism Spectrum Disorder Market - Breakup by Treatment

7.1 Behavioral Approach
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Early Intervention
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Medication
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Dietary Approach
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Autism Spectrum Disorder Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Autism Type
- 8.1.4 Market Breakup by Treatment
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Autism Type
- 8.2.4 Market Breakup by Treatment
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Autism Type
- 8.3.4 Market Breakup by Treatment
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Autism Type
- 8.4.4 Market Breakup by Treatment
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Autism Type
- 8.5.4 Market Breakup by Treatment
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Autism Type
- 8.6.4 Market Breakup by Treatment
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Autism Type
- 8.7.4 Market Breakup by Treatment
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Autism Type
- 8.8.4 Market Breakup by Treatment
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Autism Spectrum Disorder Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Services Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Services Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Services Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Services Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Services Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Autism Spectrum Disorder Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis